1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6368B57435EB0B711002585830054659D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-health-info-system-excellence-how-top-biopharmas-build-integrated-data-systems-to-fulfill-patient-centric-clinical-commercial-objectives?opendocument
18
19opendocument
2018.206.194.134
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Competitive and Business Intelligence Contracting Vendor/ Outsourcing

Health Info System Excellence: How Top Biopharmas Build Integrated Data Systems to Fulfill Patient-Centric Clinical & Commercial Objectives

ID: 5616


Features:

27 Info Graphics

10 Data Graphics

120+ Metrics

5 Narratives


Pages/Slides: 44


Published: 2020


Delivery Format: Online , PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Health Info System Excellence: How Top Biopharmas Build Integrated Data Systems to Fulfill Patient-Centric Clinical and Commercial Objectives"

STUDY OVERVIEW

A well-integrated health information system allows pharma companies to store and access aggregated insights and trends collected at numerous touchpoints throughout the patient journey and value chain of a drug. While many companies often rely on multiple vendors to help build health information systems, there needs to be alignment with the company's system to provide meaningful patient-centric services.

Best Practices, LLC conducted this research to examine how biopharma companies can work with vendors to develop fully integrated and accessible databases for aggregated health insights, often referred to as "health information systems."

This study evaluates the strengths and weaknesses of six of the industry's leading health information vendors, and illustrates how peer pharma companies utilize a mix of vendors, data types, and internal protocols to create and maintain highly effective health information systems. The study also provides new insights into the typical roles of each function relative to data collection, storage, analysis and usage.

KEY TOPICS

  • Study Overview
  • Use of Health Information Systems
  • Health Information Vendors Profiles and Ratings
  • Internal Patient-Centric Support for Health Information Systems and Vendors

SAMPLE KEY METRICS

I. Use of Health Information Systems

  • Sources of data for health information systems
  • Use of health information systems by large and small-to-mid biopharma companies
  • Biggest success stories from using aggregated anonymous information housed in a health information system
  • Limitations to realizing the benefits of health information systems
  • Main objectives for developing or using health information systems and success in achieving the said objectives
  • Primary departmental roles when utilizing health information systems
  • Departmental use of health information systems
  • Types of clinical and non-clinical research data collected by benchmark organizations

II. Health Information Vendors
  • In-house vs. outsourced construction of health information system; and Vendors used when creating a health information system

II A. Vendor Ratings
  • Performance rating of Symphony Health
  • Performance rating of IQVIA
  • Performance rating of Accenture and Corrona
  • Performance rating of Digital Reasoning Systems and Optum Health

II B. Company Profiles / SWOT Analyses
  • IQVIA’s main advantage and SWOT analysis
  • Accenture’s main offering, capabilities and SWOT analysis
  • Symphony Health’s main advantage and SWOT analysis
  • Corrona’s main offerings and SWOT analysis
  • Optum Health’s unique offering and SWOT analysis
  • Digital Reasoning Systems’ main advantage and SWOT analysis
  • Parexel’s unique offering
  • Xcenda’s unique offering
  • IBM Watson’s main advantage
  • Most critical characteristics / features desired when choosing an outsourcing partner for building an accessible health information system
  • Roles of health information vendors during each stage of health information system development
  • Methods of collaboration used when working with the selected vendors

III. Internal Patient-Centric Support for Health Information Systems and Vendors
  • Presence of a Chief Patient Officer role; Job level and title of the representative(s) who direct(s) patient centricity efforts
  • Core responsibilities fulfilled by patient centricity leaders
  • Major improvements planned to add to health information systems in the next 3 years
  • Ideal improvements to health information systems

SAMPLE KEY FINDINGS
  • Keep up with your peers by establishing a Health Information System: Two thirds of benchmarked organizations have already established health information systems.
  • Appoint a vendor liaison: Only 10% of respondents who have built these systems relied on a vendor entirely. Most others had a liaison devote time to working with the vendor to ensure it would be compatible with their existing system

METHODOLOGY

Best Practices, LLC conducted an operational health data benchmark analysis engaging 19 leaders working across 18 top life-science companies. Select responses were followed up with in qualitative interviews, which provided context to answers and allowed for a richer set of data to draw conclusions from.

Industries Profiled:
Medical Device; Biotech; Pharmaceutical; Consulting; Science; Health Care; Communications; Biopharmaceutical


Companies Profiled:
Alcon; Ascensia; Biotest AG; Boehringer Ingelheim; Central IQ; Inc.; Edward Lifesciences; GlaxoSmithKline ; Ipsen; IQVIA; Klosterfrau Healthcare Group; MEDiSTRAVA; Merck; NexGen Healthcare Communications; Novartis; Pfizer; Regeneron; Rhythm Pharmaceuticals; Sunovion

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.